Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-23 4:05 pm Purchase | 2024-08-13 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Patrick J. Crutcher | 110,851 9.900% | 110,851 (New Position) | Filing History |
| 2024-05-13 12:38 pm Purchase | 2024-05-01 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Allostery Investments LP | 78,255 7.600% | 78,255 (New Position) | Filing History |
| 2024-04-23 2:59 pm Purchase | 2024-03-27 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Emerald Bioventures LLC | 58,346 5.600% | 58,346 (New Position) | Filing History |
| 2024-04-05 4:00 pm Purchase | 2024-03-27 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Deep Track Capital, LP | 114,775 9.990% | 114,775 (New Position) | Filing History |
| 2024-02-14 9:13 pm Sale | 2023-12-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Venrock Healthcare Capital Partners III L.P. | 0 0.000% | -5,635 (Position Closed) | Filing History |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | AVALO THERAPEUTICS INC AVTX | Nantahala Capital Management, LLC | 42,100 4.900% | 39,372 (+1443.26%) | Filing History |
| 2024-02-14 4:36 pm Sale | 2023-12-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Great Point Partners, LLC | 2,085 0.260% | -1,976 (-48.66%) | Filing History |
| 2024-02-14 10:02 am Purchase | 2023-12-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Point72 Asset Management, L.P. | 2,500 0.300% | 414 (+19.85%) | Filing History |
| 2023-06-29 08:22 am Sale | 2023-06-26 | 13G | AVALO THERAPEUTICS INC AVTX | Caissa Capital Management ltd. | 0 0.000% | -6,146 (Position Closed) | Filing History |
| 2023-06-27 6:02 pm Sale | 2023-06-26 | 13D | AVALO THERAPEUTICS INC AVTX | Armistice Capital, LLC | 2,597 4.990% | -17,331 (-86.97%) | Filing History |
| 2023-04-19 4:38 pm Purchase | 2023-04-18 | 13G | AVALO THERAPEUTICS INC AVTX | Caissa Capital Management ltd. | 6,146 11.190% | 339 (+5.84%) | Filing History |
| 2023-02-17 4:05 pm Purchase | 2023-02-07 | 13G | AVALO THERAPEUTICS INC AVTX | Venrock Healthcare Capital Partners III L.P. | 5,635 9.990% | 5,635 (New Position) | Filing History |
| 2023-02-14 4:58 pm Sale | 2022-12-31 | 13G | AVALO THERAPEUTICS INC AVTX | Nantahala Capital Management, LLC | 2,728 7.000% | -228 (-7.71%) | Filing History |
| 2023-02-14 4:22 pm Sale | 2022-12-31 | 13G | AVALO THERAPEUTICS INC AVTX | Point72 Asset Management, L.P. | 2,086 5.300% | -2 (-0.10%) | Filing History |
| 2023-02-14 4:09 pm Purchase | 2023-02-14 | 13G | AVALO THERAPEUTICS INC AVTX | Caissa Capital Management ltd. | 5,807 10.570% | 1,721 (+42.12%) | Filing History |
| 2023-02-13 4:10 pm Purchase | 2023-02-03 | 13G | AVALO THERAPEUTICS INC AVTX | Great Point Partners, LLC | 4,061 7.120% | 4,061 (New Position) | Filing History |
| 2023-02-09 4:27 pm Purchase | 2023-02-07 | 13D | AVALO THERAPEUTICS INC AVTX | Armistice Capital, LLC | 19,928 35.400% | 1,876 (+10.39%) | Filing History |
| 2022-08-11 4:09 pm Unchanged | 2022-08-08 | 13D | AVALO THERAPEUTICS INC AVTX | Armistice Capital, LLC | 18,052 44.400% | 0 (Unchanged) | Filing History |
| 2022-08-08 07:23 am Purchase | 2022-07-25 | 13G | AVALO THERAPEUTICS INC AVTX | Caissa Capital Management ltd. | 4,086 10.430% | 1,968 (+92.92%) | Filing History |
| 2022-05-17 3:45 pm Purchase | 2022-05-04 | 13G | AVALO THERAPEUTICS INC AVTX | Caissa Capital Management ltd. | 2,118 5.410% | 2,118 (New Position) | Filing History |